EMERALD ADVISERS, LLC – Blueprint Medicines Corporation Transaction History
EMERALD ADVISERS, LLC portfolio value:
$20.99M
portfolio value
Blueprint Medicines Corporation 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | 0.00% | 318.57K shares | 20.99M | $65.89 | 318.57K |
| Q1 2022 | share | Decrease | -100.00% | -169.65K shares | -18.17M | $63.88 | 0 |
| Q4 2021 | share | Decrease | -27.34% | -63.84K shares | -5.83M | $109.45 | 169.65K |
| Q3 2021 | share | Increase | +3.17% | 7.17K shares | 4.09M | $102.81 | 233.50K |
| Q2 2021 | share | Decrease | -12.99% | -33.79K shares | -5.38M | $87.96 | 226.33K |
| Q1 2021 | share | Decrease | -12.68% | -37.77K shares | -8.11M | $97.23 | 260.13K |
| Q4 2020 | share | Decrease | -21.73% | -82.68K shares | -1.87M | $112.15 | 297.90K |
| Q3 2020 | share | Decrease | -3.77% | -14.89K shares | 4.43M | $92.7 | 380.58K |
| Q2 2020 | share | Decrease | -4.97% | -20.68K shares | 6.51M | $78 | 395.48K |
| Q1 2020 | share | Increase | 0.00% | 416.16K shares | 24.33M | $58.48 | 416.16K |